메뉴 건너뛰기




Volumn 65, Issue 1, 2004, Pages 132-133

Worsened agitation with aripiprazole: Adverse effect of dopamine partial agonism?

Author keywords

[No Author keywords available]

Indexed keywords

ARIPIPRAZOLE; NEUROLEPTIC AGENT; PIPERAZINE DERIVATIVE; QUINOLONE DERIVATIVE;

EID: 1442332132     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.v65n0122b     Document Type: Letter
Times cited : (38)

References (3)
  • 1
    • 0036738786 scopus 로고    scopus 로고
    • Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder
    • Kane JM, Carson WH, Saha AR, et al. Efficacy and safety of aripiprazole and haloperidol versus placebo in patients with schizophrenia and schizoaffective disorder. J Clin Psychiatry 2002;63:763-771
    • (2002) J Clin Psychiatry , vol.63 , pp. 763-771
    • Kane, J.M.1    Carson, W.H.2    Saha, A.R.3
  • 2
    • 0035094264 scopus 로고    scopus 로고
    • 2 receptor explain the action of atypical antipsychotics? A new hypothesis
    • 2 receptor explain the action of atypical antipsychotics? a new hypothesis. Am J Psychiatry 2001;158:360-369
    • (2001) Am J Psychiatry , vol.158 , pp. 360-369
    • Kapur, S.1    Seeman, P.2
  • 3
    • 27444437101 scopus 로고    scopus 로고
    • Rockville, Md: Otsuka Pharmaceutical Co Ltd
    • Abilify [package insert]. Rockville, Md: Otsuka Pharmaceutical Co Ltd; 2002
    • (2002) Abilify [Package Insert]


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.